These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. [Endocrinologie and obesity]. Maier C; Luger A Acta Med Austriaca; 2004; 31(4):112-4. PubMed ID: 15732244 [TBL] [Abstract][Full Text] [Related]
67. Endocrine factors and risk of venous thrombosis. Masi AT Milbank Mem Fund Q; 1972 Jan; 50(1):Suppl 2:46-59. PubMed ID: 4555350 [No Abstract] [Full Text] [Related]
68. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome? Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887 [TBL] [Abstract][Full Text] [Related]
69. The emerging biology of adipose tissue in chronic kidney disease: from fat to facts. Axelsson J Nephrol Dial Transplant; 2008 Oct; 23(10):3041-6. PubMed ID: 18632589 [No Abstract] [Full Text] [Related]
70. [The adipose tissue as an endocrine organ]. Szendrödi J; Roden M Acta Med Austriaca; 2004; 31(4):98-111. PubMed ID: 15732243 [TBL] [Abstract][Full Text] [Related]
71. [Outline of the pathogenesis of obesity]. Tatoń J Pol Tyg Lek; 1995; Suppl 1():3-10. PubMed ID: 7596904 [No Abstract] [Full Text] [Related]
72. Prevention of obesity: a review of interventions. Brown T; Kelly S; Summerbell C Obes Rev; 2007 Mar; 8 Suppl 1():127-30. PubMed ID: 17316315 [No Abstract] [Full Text] [Related]
73. Resistance exercise training: its role in the prevention of cardiovascular disease. Braith RW; Stewart KJ Circulation; 2006 Jun; 113(22):2642-50. PubMed ID: 16754812 [No Abstract] [Full Text] [Related]